Other proteins found to be over-expressed in SCC are TTL12 and HAT1, previously reported to be associated with prostate cancer or lymphoma and esophageal squamous cell carcinoma progression, respectively (Supplementary Tables 6 and 9). This evidence concerns the gene HAT1 and prostate carcinoma.